Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis
To access this article, please choose from the options below
PII: S0145-2126(08)00567-5
doi:10.1016/j.leukres.2008.12.020
© 2008 Elsevier Ltd. All rights reserved.
